OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3026% below fair value
$7.31+0.37 (+5.33%)
Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –
OptimizeRx net income
Net income is the profit left for shareholders after every expense, interest and tax.
OptimizeRx's net income for the twelve months ending Jun 30, 2026 was $4.60M. For fiscal 2025 it was $5.13M. The highest annual figure on record is $5.13M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.13M | – |
| FY2024 | Dec 31, 2024 | -$20.11M | – |
| FY2023 | Dec 31, 2023 | -$17.57M | – |
| FY2022 | Dec 31, 2022 | -$11.44M | -3125.4% |
| FY2021 | Dec 31, 2021 | $378.08K | – |
| FY2020 | Dec 31, 2020 | -$2.21M | – |
| FY2019 | Dec 31, 2019 | -$3.14M | -1488.4% |
| FY2018 | Dec 31, 2018 | $226.34K | – |
| FY2017 | Dec 31, 2017 | -$2.10M | – |
| FY2016 | Dec 31, 2016 | -$1.54M | – |
| FY2015 | Dec 31, 2015 | -$595.14K | – |
| FY2014 | Dec 31, 2014 | -$1.03M | – |
| FY2013 | Dec 31, 2013 | -$267.29K | – |
| FY2012 | Dec 31, 2012 | -$454.55K | – |
| FY2011 | Dec 31, 2011 | -$2.12M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$703.00K | -145.9% |
| Q1 FY2026 | Mar 31, 2026 | -$495.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $5.02M | – |
| Q3 FY2025 | Sep 30, 2025 | $779.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $1.53M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$78.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.12M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.01M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.90M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.87M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.16M | -767.4% |
| Q1 FY2023 | Mar 31, 2023 | -$6.40M | -16137.5% |
| Q4 FY2022 | Dec 31, 2022 | -$325.84K | -192.5% |
| Q1 FY2022 | Mar 31, 2022 | -$3.76M | – |
| Q4 FY2021 | Dec 31, 2021 | $623.46K | -54.1% |
| Q3 FY2021 | Sep 30, 2021 | $39.89K | – |
| Q2 FY2021 | Jun 30, 2021 | $352.10K | – |
| Q1 FY2021 | Mar 31, 2021 | -$637.38K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.36M | +233.8% |
| Q3 FY2020 | Sep 30, 2020 | -$282.89K | -4432.9% |
| Q2 FY2020 | Jun 30, 2020 | -$1.08M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.20M | -999.8% |
| Q2 FY2019 | Jun 30, 2019 | $406.62K | +45.0% |
| Q1 FY2019 | Mar 31, 2019 | $6.53K | – |
| Q4 FY2018 | Dec 31, 2018 | -$109.91K | – |
| Q3 FY2018 | Sep 30, 2018 | $244.93K | – |
| Q2 FY2018 | Jun 30, 2018 | $280.51K | – |
| Q1 FY2018 | Mar 31, 2018 | -$189.18K | – |
| Q4 FY2017 | Dec 31, 2017 | -$237.06K | – |
| Q3 FY2017 | Sep 30, 2017 | -$622.79K | – |
| Q2 FY2017 | Jun 30, 2017 | -$361.50K | – |
| Q1 FY2017 | Mar 31, 2017 | -$882.68K | – |
| Q4 FY2016 | Dec 31, 2016 | -$352.75K | – |
| Q3 FY2016 | Sep 30, 2016 | -$242.58K | – |
| Q2 FY2016 | Jun 30, 2016 | -$591.93K | – |
| Q1 FY2016 | Mar 31, 2016 | -$351.92K | – |
See a number that looks wrong?